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Chronic or non-healing ulcerations of the lower extremity are a
major source of disability, morbidity and mortality in people
with varicose veins and diabetes. They account for a large portion
of the ¢nancial burden in dermatology. Therefore, the key to
promoting healing in chronic ulcers is to understand the di¡erent
processes in normal and impaired wound healing. Cutaneous
wound healing is a highly complex process involving ¢ve over-
lapping phases (in£ammation, granulation tissue formation,
epithelialization, matrix production, and remodeling) associated
with a number of migratory and remodeling events that are be-
lieved to require the action of matrix metalloproteinases (MMPs)
and their inhibitors,TIMPs. In vivo analyses of human acute and
chronic wounds as well as of a variety of di¡erent wound healing
models have implicated a functional role of MMPs and TIMPs
during normal wound repair, whereas misregulation of their
activity is believed to contribute to impaired wound healing.
Degradation of extracellular matrices is needed to remove
damaged tissue and provisional matrices and to permit vessel
formation and reepithelialization. In contrast, in chronic or
nonhealing wounds overexpression of proteinases in their inac-
tive form is thought to contribute to the underlying pathology
and to inhibit normal tissue repair processes.(Park et al, 1999)
In this issue of the Journal Hieta et al report on the expression of
MMP-19 in granulating and chronic ulcers depicting MMP-19
protein in ¢broblasts of the granulation tissue, in microvascular
endothelial cells, and in macrophages (2003). No di¡erence in
the expression pattern of this proteinase was noted in either
healing or nonhealing ulcers. The authors then show that
in vitro production of MMP-19 by human skin ¢broblasts
is induced by several cytokines, of which TNF-a, a pleiotropic
cytokine produced by a variety of cell types including macro-
phages, keratinocytes, mast cells and T cells had the strongest in-
ducing e¡ect. Using elegant technologies, they elaborate and
dissect the signaling pathways involved in the regulation of
MMP-19.
What do we currently know about MMP-19? This enzyme has
previously been characterized by Sedlacek et al (1998) as an autoanti-
gen in in£amed rheumatoid synovium. Multi-tissue expression ana-
lyses provide evidence that MMP-19 is widely expressed in many
organs including lung, spleen, intestine, pancreas, ovary, and placen-
ta. In addition, Impola et al (2003) have recently shown that MMP-
19 expression is lost with malignant transformation in the invading
part of basal and squamous cell carcinomas.While MMP-19 was not
detected within the epidermis in normal skin, in psoriasis as well as
in healing wounds Suomela et al (2003) found MMP-19 protein in
the hyperproliferative epithelium in basal and suprabasal keratino-
cytes and in proliferating basal keratinocytes neighboring the mi-
grating edge, suggesting an association with cell proliferation.
Similar to most MMPs, MMP-19 is not expressed in normal,
healthy skin, while its expression is seen in repair and remodeling
in diseased and in£amed tissue. The physiological function of this
metalloproteinase, however, is largely unknown.
Previously, Madlener et al (1998) reported that reepithelializa-
tion is associated with active production of MMP-1, MMP-9,
and the stromelysins MMP-3 and MMP-10, which were pro-
duced by separated populations of basal keratinocytes. Saarialho-
Kere et al (1998) showed in their immunohistochemical and in situ
hybridization studies that MMP-10 (stromelysin-2) colocalized
with MMP-1 in migrating cells of the edge, while MMP-3 (stro-
melysin-1), similar to MMP-19 described here by Hieta et al, was
mainly detected in the neighboring hyperproliferative population
of basal keratinocytes. During later phases of wound repair
MMP-19 is expressed in the granulation tissue by resident and in-
¢ltrating cells including (myo-)¢broblasts and endothelial cells.
This ¢nding is similar to that described for a variety of MMPs,
e.g., MMP-2 (Gelatinase A) and MMP-14 (MT1-MMP). The
addition of MMP-19 to the list of MMPs expressed in healing
wounds underlines the complex process of wound repair. How-
ever, it also raises the question about the function of MMPs dur-
ing tissue repair and regeneration.
Stracke et al (2000) have identi¢ed various substrates of MMP-
19 including type IV collagen, gelatin, laminin-1, nidogen-1,
¢bronectin, and tenascin-C.These in vitro studies were performed
using a recombinant catalytic domain of MMP-19; however, si-
milar to other MMPs it is not clear whether the substrates
cleaved in vitro will be degraded in vivo. With the exception of
the interstitial collagenases, MMP-1 and MMP-8, cleaving the ¢-
brillar collagens I, II and III, most MMPs have no speci¢c sub-
strate speci¢city and act on many di¡erent proteins. In addition,
many MMPs can degrade the same substrates, indicating redun-
dancy among MMPs. In the past decade transgenic animals with
overexpression, or complete or tissue-speci¢c inactivation of var-
ious genes have been produced to improve our understanding of
the function of individual proteins.With the exception of MMP-
14-de¢cient mice, which develop ¢brosis of the dermis, none of
the presently known MMP knockout mice display a severe skin
phenotype in unchallenged animals. However, several MMP
knockout mice show a phenotype when challenged by injury,
and in particular by infection and tumorigenesis.With regard to
wound healing, only mice lacking MMP-3 showed a delayed
healing of excisional wounds with impaired tissue contraction
(Bullard et al, 1999). However, reepithelialization was unaltered
in MMP-3- and MMP-9-de¢cient mice, although these enzymes
are induced in keratinocytes of healing wounds. Although
MMPs are known to be involved in regulating connective tissue
metabolism it is not surprising that little change in wound heal-
ing is observed in the individual MMP-knockout animals. From
a biological viewpoint it is understandable that processes that are
so essential to survival cannot rely on only one particular enzyme.
The observations on the MMP knockout animals described
above indicate that other MMPs or other classes of proteinases,
e.g., serine proteases, sharing a similar function and substrate
speci¢city, can compensate for the lack of an individual MMP.
Interestingly, inactivation of the genes coding for the potential
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MMP-activator plasminogen, and the plasminogen activators tPA
and uPA, resulted in a severe wound healing phenotype (Carme-
liet et al, 1994; Romer et al, 1996).
Hieta et al also made the important observation that macro-
phages located in the wound bed produce MMP-19 protein. This
¢nding corroborates the data published by Sedlacek et al (1998)
and Mauch et al (2002), who detected MMP-19 in blood mono-
nuclear cells and myeloid cells. More importantly, this latter
group was able to show that MMP-19 which is released as a
soluble form by myeloid cell lines, appeared as a cell surface-
associated protein form in di¡erentiated monocytes and macro-
phages suggesting that MMP-19 might contribute to the distinct
migration capabilities of blood-derived cells. Our current knowl-
edge about the role of macrophages during wound healing is still
limited. During the in£ammatory phase macrophages are lured
into the wound site through the action of biologically active fac-
tors released by platelets and leukocytes. Macrophages can secrete
a variety of MMPs, including MMP-1 and MMP-12, that seem to
be produced at distinct stages of wound repair. These cells are be-
lieved to be crucial to the wound healing process since they re-
move cellular debris and release a large number of growth
factors. Does MMP-19 facilitate migration of macrophages with-
in the wound bed? Is it involved in the release of membrane-as-
sociated cytokines and growth factors as has been shown for the
activation of TNF-a byTACE? Martin et al (2003) have very re-
cently shaken the dogma on the importance of in£ammatory cells
in wound healing by showing that in PU.1 null mice, which lack
macrophages and functioning neutrophils, excisional wounds
heal completely normally, suggesting that tissue repair is not de-
pendent on in£ammatory cells. However, they also observed that
instead of macrophages, ‘‘stand-in’’ ¢broblast phagocytes cleared
cell and matrix debris, and no data were included on the expres-
sion of MMPs in these wounds.
The data discussed above clearly emphasize the di⁄culty in
determining the precise function of a metalloproteinase in a
complex process such as wound healing. Therefore, the research
on wound healing must be encouraged to continously add miss-
ing pieces to the puzzle and to improve our understanding of
tissue repair and remodeling.
REFERENCES
Bullard KM, Lund L, Mudgett JS, et al: Impaired wound contraction in stromelysin-
1-de¢cient mice. Ann Surg 230:260^265, 1999
Carmeliet P, Schoonjans J, Kieckens L, et al: Physiological consequences of loss of
plasminogen activator gene function in mice. Nature 368:419^424, 1994
Hieta N, Impola U, Lopez-Otin C, Saarialho-Kere U, Kahari V-M: Matrix metallo-
proteinase-19 expression in dermal wounds and by ¢broblasts in culture.
J Invest Dermatol 121:997^1004, 2003
Impola U,Toriseva M, Suomela S, et al: Matrix Metalloproteinase-19 is expressed by
proliferating epithelium but disappears with neoplastic dedi¡erentiation. Int J
Cancer 103:709^716, 2003
Madlener M, Parks WC, Werner S: Matrix Metalloproteinases (MMPs) and their
physiological inhibitors (TIMPs) are di¡erentially expressed during excisional
skin wound repair. Exp Cell Res 242:201^210, 1998
Martin P, D’Souza D, Martin J, Grose R, Cooper L, Maki R, McKercher SR:
Wound healing in the PU.1 null mouse ^ tissue repair is not dependent on
in£ammatory cells. Current Biol 13:1122^1128, 2003
Mauch S, Kolb C, Kolb B, Sadowski T, Sedlacek R: Matrix Metalloproteinase-19 is
expressed in myeloid cells in an adhesion-dependent manner and associates
with the cell surface. J Immunol 168:1244^1251, 2002
ParksWC: Matrix Metalloproteinases in repair.Wound Rep Reg 7:423^432, 1999
Romer J, BuggeTH, Pyke C, Lund LR, Flick MJ, Degen JL, Dano K: Impaired wound
healing in mice with a disrupted plasminogen gene. Nat Med 2:287^292, 1996
Sedlacek R, Mauch S, Kolb B, et al: Matrix metalloproteinase MMP-19 (RASI-1) is
expressed on the surface of activated peripheral blood mononuclear cells and is
detected as an autoantigen in rheumatoid arthritis. Immunobiology 198:408^423,
1998
Saarialho-Kere UK: Patterns of matrix metalloproteinase and TIMP expression in
chronic ulcers. Arch Dermatol Res 290:S47^54, 1998
Stracke JO, Hutton M, Stewart M, et al: Biochemical characterization of the catalytic
domain of human matrix metalloproteinase-19. Evidence for a role as a potent
basement membrane degrading enzyme. J Biol Chem 275:14809^14816, 2000
Suomela S, Kariniemi A-L, Impola U, et al: Matrix Metalloproteinase-19 is expressed
by keratinocytes in psoriasis. Acta DermVenereol 83:108^114, 2003
xx MAUCH THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
